ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers

Active 4

1
Lyons, Emer
Born in January 1978
Individual (10 offsprings)
Officer
2023-10-12 ~ now
OF - Director → CIF 0
2
Fox, Erina
Individual (30 offsprings)
Officer
2020-01-22 ~ now
OF - Secretary → CIF 0
3
Hollywood, Simon
Born in January 1980
Individual (5 offsprings)
Officer
2023-10-12 ~ now
OF - Director → CIF 0
4
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED
- now
MEDPASS GROUP LIMITED - 2021-04-19
500, South Oak Way, Green Park, Reading, United Kingdom
Active Corporate (4 parents)
Equity (Company account)
32,145,059 GBP2023-12-31
Person with significant control
2016-04-06 ~ now
PE - Ownership of voting rights - 75% or more → CIF 0
PE - Ownership of shares – 75% or more → CIF 0

Ceased 5

1
Grove, Harvey Gordon Edwin
Chartered Accountant born in May 1948
Individual
Officer
2012-12-11 ~ 2021-04-08
OF - Director → CIF 0
2
Sorrel, Sarah Anne
Company Director born in September 1957
Individual
Officer
2012-12-11 ~ 2021-04-08
OF - Director → CIF 0
3
Gleeson, Michael
Director born in November 1978
Individual (9 offsprings)
Officer
2020-01-22 ~ 2022-10-21
OF - Director → CIF 0
4
O'boyle, Bryan
Director born in October 1982
Individual
Officer
2020-01-22 ~ 2023-10-12
OF - Director → CIF 0
5
Harte, Brendan
Director born in May 1965
Individual
Officer
2020-01-22 ~ 2023-10-12
OF - Director → CIF 0

Company in focus

Previous names

MEDPASS LIMITED - 2021-04-19

MEDPASS INTERNATIONAL HOLDINGS LIMITED - 2014-01-10

Standard Industrial Classification

70100 - Activities Of Head Offices

Brief company account

Cost of Sales

-42,973 GBP2022-01-01 ~ 2022-12-31

Gross Profit/Loss

-42,973 GBP2022-01-01 ~ 2022-12-31

Administrative Expenses

1,820 GBP2023-01-01 ~ 2023-12-31

-171,672 GBP2022-01-01 ~ 2022-12-31

Distribution Costs

253,055 GBP2023-01-01 ~ 2023-12-31

71,795 GBP2022-01-01 ~ 2022-12-31

Operating Profit/Loss

254,875 GBP2023-01-01 ~ 2023-12-31

-142,850 GBP2022-01-01 ~ 2022-12-31

Other Interest Receivable/Similar Income (Finance Income)

3,491 GBP2022-01-01 ~ 2022-12-31

Profit/Loss on Ordinary Activities Before Tax

254,875 GBP2023-01-01 ~ 2023-12-31

-139,359 GBP2022-01-01 ~ 2022-12-31

Profit/Loss

257,384 GBP2023-01-01 ~ 2023-12-31

-139,359 GBP2022-01-01 ~ 2022-12-31

Debtors

1,397,243 GBP2023-12-31

1,489,674 GBP2022-12-31

Cash at bank and in hand

95,891 GBP2023-12-31

5,027 GBP2022-12-31

Current Assets

1,493,134 GBP2023-12-31

1,494,701 GBP2022-12-31

Net Assets/Liabilities

1,493,134 GBP2023-12-31

1,235,750 GBP2022-12-31

Equity

Called up share capital

100 GBP2023-12-31

100 GBP2022-12-31

100 GBP2021-12-31

Retained earnings (accumulated losses)

1,493,034 GBP2023-12-31

1,235,650 GBP2022-12-31

1,375,009 GBP2021-12-31

Equity

1,493,134 GBP2023-12-31

1,235,750 GBP2022-12-31

1,375,109 GBP2021-12-31

Profit/Loss

Retained earnings (accumulated losses)

257,384 GBP2023-01-01 ~ 2023-12-31

-139,359 GBP2022-01-01 ~ 2022-12-31

Wages/Salaries

37,072 GBP2022-01-01 ~ 2022-12-31

Social Security Costs

4,166 GBP2022-01-01 ~ 2022-12-31

Staff Costs/Employee Benefits Expense

42,973 GBP2022-01-01 ~ 2022-12-31

Average number of employees in administration and support functions

12023-01-01 ~ 2023-12-31

12022-01-01 ~ 2022-12-31

Average Number of Employees

32023-01-01 ~ 2023-12-31

42022-01-01 ~ 2022-12-31

Audit Fees/Expenses

2,100 GBP2023-01-01 ~ 2023-12-31

2,000 GBP2022-01-01 ~ 2022-12-31

Tax Expense/Credit at Applicable Tax Rate

59,948 GBP2023-01-01 ~ 2023-12-31

-26,478 GBP2022-01-01 ~ 2022-12-31

Amounts Owed By Related Parties

1,397,243 GBP2023-12-31

1,393,403 GBP2022-12-31

Other Debtors

100 GBP2022-12-31

Amounts Owed to Related Parties

251,694 GBP2022-12-31

Par Value of Share

Class 2 ordinary share

12023-01-01 ~ 2023-12-31

Number of Shares Issued (Fully Paid)

Class 2 ordinary share

70 shares2023-12-31

70 shares2022-12-31

Par Value of Share

Class 3 ordinary share

12023-01-01 ~ 2023-12-31

Number of Shares Issued (Fully Paid)

Class 3 ordinary share

10 shares2023-12-31

10 shares2022-12-31

Par Value of Share

Class 4 ordinary share

12023-01-01 ~ 2023-12-31

Number of Shares Issued (Fully Paid)

Class 4 ordinary share

10 shares2023-12-31

10 shares2022-12-31

Number of Shares Issued (Fully Paid)

100 shares2023-12-31

100 shares2022-12-31

ICON CLINICAL RESEARCH (U.K.) NO. 5 LIMITED
Info
MEDPASS LIMITED - 2021-04-19
MEDPASS INTERNATIONAL HOLDINGS LIMITED - 2021-04-19
Registered number 08326602
3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP
PRIVATE LIMITED COMPANY incorporated on 2012-12-11 (13 years). The company status is Active.
The last date of confirmation statement was made at 2025-03-15
CIF 0

Offspring entities and appointments

Active 0

Not found in our database.